MIAMI BEACH, Fla., April 27, 2018 -- via OTC PR WIRE -- SNM Global Holdings (OTC:SNMN) is excited to announce the assembly of a group of medical cannabis industry experts from the financial, medical, and legal sectors.
During the recent legislative session in the Maryland legislature, a bill was passed to authorize the Maryland Medical Cannabis Commission to reopen the application process and grant several additional Medical Cannabis Grower and Processor licenses throughout the state. We will be working diligently over the next several months to complete the application process, identify key areas within the state of Maryland for suitable facilities, and engage horticulture experts, as well as seasoned medical operations personnel to position SNM to be awarded either one or both of these new license opportunities.
"SNM is excited to have become involved with industry experts in each stage of the medical cannabis arena, from grow operations all the way down to retail sales at the dispensary level," stated SNM CEO Troy Lowman, "the legal counsel we have retained to assist us with our Grower and Processing applications to the Maryland Medical Cannabis Commission has a proven track record of assisting their clients in acquiring various medical cannabis licenses." “It is very humbling to realize we will be a part of a rapidly developing industry that will help so many people achieve quality of life living while with cancer and so many other diseases,” says Lowman.
The process from application to becoming fully operational is expected to take approximately 365 days.
Contact Information
Troy Lowman, CEO
Phone (410)733-6551
Email: [email protected]
Safe Harbor for Forward-Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospect s and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commissions. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 



